Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B3 | P37058 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | MAOB | P27338 | 3/20 | 0.56 |
| ▸ | MAOA | P21397 | 2/20 | 0.56 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.56 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | RELA | Q04206 | 1/20 | 0.50 |
| ▸ | BACE1 | P56817 | 1/20 | 0.50 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL699998 | 1.00 | HSD17B3 (0.59) | HSD17B3ALDH1A1MAOBMAOANFE2L2 | |
| SCHEMBL8900441 | 0.93 | HSD17B3 (0.65) | HSD17B3ALDH1A1MAOBMAOANFE2L2 | |
| SCHEMBL699462 | 0.93 | HSD17B3 (0.65) | HSD17B3ALDH1A1MAOBMAOANFE2L2 | |
| SCHEMBL709614 | 0.93 | HSD17B3 (0.65) | HSD17B3ALDH1A1MAOBMAOANFE2L2 | |
| SCHEMBL699611 | 0.88 | HSD17B3 (0.57) | HSD17B3ALDH1A1MAOBMAOANFE2L2 | |
| SCHEMBL699610 | 0.88 | HSD17B3 (0.57) | HSD17B3ALDH1A1MAOBMAOANFE2L2 | |
| SCHEMBL8900696 | 0.88 | HSD17B3 (0.57) | HSD17B3ALDH1A1MAOBMAOANFE2L2 | |
| SCHEMBL5617768 | 0.85 | RELA (0.47) | HSD17B3ALDH1A1MAOBMAOANFE2L2 | |
| SCHEMBL6520699 | 0.85 | NPC1 (0.59) | HSD17B3ALDH1A1MAOBMAOANFE2L2 | |
| SCHEMBL25313708 | 0.83 | TTR (0.48) | ALDH1A1MAOBMAOANFE2L2CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021074275-A1 | EFFECTIVE PHOTOMODULATION OF LANTHANIDE (III) ION LUMINESCENCE IN THE VISIBLE OR NEAR-INFRARED RANGE | UNIVERSITE DE RENNES 1 (FR) | 2021-04-22 | — | — | WO | disclosed |
| CN-110256192-A | It is a kind of using alcohol be hydrogen source Photocatalysis selectivity synthesis cis and trans olefins process | 南通大学 | 2019-09-20 | — | — | CN | disclosed |
| CN-110218141-A | A kind of Photocatalysis selectivity synthesis Z- and E- olefins process | 南通大学 | 2019-09-10 | — | — | CN | disclosed |
| CN-109134172-A | The alcohol hydrogen supply iridium catalytic selectivity of ligand regulation synthesizes Z- and E- olefins process | 南通大学 | 2019-01-04 | — | — | CN | disclosed |
| US-9868873-B2 | Photochromic security enabled ink for digital offset printing applications | XEROX CORPORATION (US) | 2018-01-16 | — | — | US | disclosed |
| US-8703388-B2 | Optical data storage media | GENERAL ELECTRIC COMPANY (US) | 2014-04-22 | — | — | US | disclosed |
| US-20130305947-A1 | PHOTOCHROMIC SECURITY ENABLED INK FOR DIGITAL OFFSET PRINTING APPLICATIONS | XEROX CORPORATION (US) | 2013-11-21 | — | — | US | disclosed |
| US-8507153-B2 | Compositions, optical data storage media and methods for using the optical data storage media | GENERAL ELECTRIC COMPANY (US) | 2013-08-13 | — | — | US | disclosed |
| EP-2423917-B1 | Use of chemically bonded dyes in holographic data storage media | GEN ELECTRIC (US) | 2013-08-07 | — | — | EP | disclosed |
| US-8343608-B2 | Use of appended dyes in optical data storage media | GENERAL ELECTRIC COMPANY (US) | 2013-01-01 | — | — | US | disclosed |
| US-20040100188-A1 | Anthracene derivative and organic electroluminescence device using the derivative | IDEMITSU KOSAN CO., LTD. (JP) | 2004-05-27 | — | — | US | disclosed |
| CN-1365347-A | Anthracene derivative and electroluminescent device using the same | IDEMITSU KOSAN CO (JP) | 2002-08-21 | — | — | CN | disclosed |
| US-20020048687-A1 | Anthracene derivative and organic electroluminescence device using the derivative | IDEMITSU KOSAN CO., LTD. (JP) | 2002-04-25 | — | — | US | disclosed |
| EP-1182183-A1 | ANTHRACENE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICES MADE BY USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2002-02-27 | — | — | EP | disclosed |
| US-20020015906-A1 | Polymer for photoresist, method of production thereof and photoresist composition containing polymer | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2002-02-07 | — | — | US | disclosed |
| US-5759729-A | A DRY TONER COMPRISING A RESIN, PHOTOCHROMATIC SPIROPYRAN, -OXAZINE OR -THIOPYRAN DYE AND A CHARGE CONTROL AGENT;ELECTROGRAPHY; XEROGRAPHY | XEROX CORPORATION (US) | 1998-06-02 | — | — | US | disclosed |
| US-5710420-A | Method for embedding and recovering machine-readable information | XEROX CORPORATION (US) | 1998-01-20 | — | — | US | disclosed |
| US-5633109-A | Ink compositions with liposomes containing photochromic compounds | XEROX CORPORATION (US) | 1997-05-27 | — | — | US | disclosed |
| US-5593486-A | Photochromic hot melt ink compositions | XEROX CORPORATION (US) | 1997-01-14 | — | — | US | disclosed |
| US-5551973-A | LIQUID CRYSTAL GEL PHASE, MICROEMULSION PHASE | XEROX CORPORATION (US) | 1996-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040100188-A1 | Anthracene derivative and organic electroluminescence device using the derivative | ACIN1, KCNQ1, LBR | HSD17B3 1463/4885ALDH1A1 200/4885MAOB 1336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.